GPT and metabolic dysfunction-associated steatotic liver disease: Participants with MHO at baseline, compared with MUHO, were younger, were more likely to be female, had better metabolic profile with lower BP, FBG, HbA1c, HOMA-IR, ALT, AST and lipid profile, had higher portion of patients with hypertension, NAFLD and carotid atherosclerosis and were less likely to be a current smoker (Table S1).